Polymorphic forms and process

A polymorph of a compound of formula (I)

• wherein the polymorph is 3,3′-Dideoxy-3,3′-bis-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1,1′-sulfanediyl-di-β-D-galactopyranoside and wherein:
• the polymorph has a polymorphic form 1 as identified in the following XRPD diffractogram peak list:
• No.
• Pos. [°2Th.]
• Rel. Int. [%]
• 1
• 7.1269
• 77.72
• 2
• 7.5067
• 56
• 3
• 10.125
• 36.86
• 4
• 14.3791
• 32.28
• 5
• 15.0846
• 18.59
• 6
• 15.8201
• 35.78
• 7
• 16.7088
• 78.1
• 8
• 18.6001
• 21.29
• 9
• 19.7777
• 100
• 10
• 20.3353
• 57.04
• 11
• 21.7744
• 79.92
• 12
• 22.6053
• 35.8
• 13
• 23.4305
• 45.78
• 14
• 24.3658
• 51.03
• 15
• 25.8091
• 54.36
• 16
• 26.7046
• 25.38
• 17
• 29.028
• 16.19
• 18
• 30.2989
• 28.02
• 19
• 32.2693
• 14.86
• 20
• 33.5132
• 11.55
• 21
• 34.6078
• 11.54
• 22
• 35.8435
• 9.6
• 23
• 44.6257
• 22.73;
• or
• the polymorph has a polymorphic form 1 as identified in the XRPD diffractogram in FIG. 1.